Von Pawel J.The role of topotecan in treating small cell lungcancer:second line treatment. Lung Cancer . 2003Von Pawel J. The role of topotecan in treating small cell lung cancer: second-line treatment [ J ]. Lung Cancer,2(X)3,41 ( Suppl 4 ) : S3 -S8....
Lung CancerEttinger DS. New drugs for treating small cell lung cancer. Lung Cancer 1995 Jun; 12 Suppl. 3: S53–61Ettinger, D. S. (1995). New drugs for treating small cell lung can- cer. Lung Cancer 12(Suppl. 3), S53-S61.
A method for treating small cell lung cancer (SCLC). In the method, a therapeutically effective amount of a compound of Formula I:; <Chemistry id="CHEM-US-00001"> </Chemistry> ;wherein R<Sup>1</Sup>, R<Sup>2 </Sup>and R<Sup>3 </Sup>have the definitions disclosed in the specifi...
Clinical observation of docetaxel in treating advanced non-small cell lung cancer in the elderly patients 摘要: Y Cai,X Xin,L Ming - 《肿瘤学与转化医学(英文)》 被引量: 18发表: 2010年 Clinical observation of docetaxel in treating advanced non-small cell lung cancer in the elderly patients ...
Hi. I was diagnosed with small cell lung cancer. I am treating my lung cancer with chemotherapy. They said surgery has no influence on survival. I am sick of ch This topic is answered by a medical expert.
celllungcancerpatritumabU3-1287AMG-888HidehitoDepartmentHorinouchiDepartmentInformaworldExpert Opinion on Biological TherapyHorinouchi H 2016 The prospect of patritumab for treating non-small cell lung cancer Expert Opin. Biol. Ther. 16 1549-55...
In a study recently published in the journalPharmaceutics, berberine’s impact on non-small cell lung cancer has been evaluated. It demonstrates that berberine has significant anticancer activity, suppressing the growth of cancer cells in vitro. ...
A method for treating small cell lung cancer (SCLC) is provided. In the method, a therapeutically effective amount of a compound of Formula I: (I) wherein ... TL Su,TC Lee 被引量: 0发表: 0年 ANTICANCER COMBINATION OF A DAC INHIBITOR AND A TYROSINE KINASE INHIBITOR The present inventio...
Novel KRAS Inhibitors for Treating Non-small Cell Lung Cancer Provided herein are novel KRAS inhibitors, pharmaceutical compositions, use of such compounds in treating non-small cell lung cancer, and processes for pre... Ram W. Sabnis 被引量: 0发表: 0年 Rationale and design of MARQUEE: a ...
Indeed, small-molecule-based inhibitors of glutaminase, an enzyme crucial to glutamine metabolism, slowed cancer cell growth and led to smaller tumors overall in human lung adenocarcinoma cell lines and in tumors in mice with KEAP1 mutations, the researchers found. ...